Laura Gianserra

Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

Velia Chiara Di Maio, Valeria Cento, Ilaria Lenci et al. · Liver International · 2017 · 90 citations · Full text

Life Sciences, Infectious Diseases, Clinical Pharmacology +11

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy

Ada Bertoli, M.C. Sorbo, M. Aragri et al. · Scientific Reports · 2018 · 48 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Cortical sources of resting-state EEG rhythms are abnormal in naïve HIV subjects

Claudio Babiloni, Paola Buffo, Paolo Onorati et al. · Clinical Neurophysiology · 2012 · 26 citations

Life Sciences, Neurology, Neuroscience +14

Cortical sources of resting-state EEG rhythms in “experienced” HIV subjects under antiretroviral therapy

Claudio Babiloni, Paola Buffo, Paolo Onorati et al. · Clinical Neurophysiology · 2014 · 20 citations

Life Sciences, Neurology, Neuroscience +14

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Valeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo et al. · PLoS ONE · 2017 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17